The factor-X inhibitor was no worse than vitamin K antagonists in preventing stroke and thromboembolism but caused significantly more bleeding. Medscape Medical News
Frank Sacks, MD, provides an overview on CVD risk factors in patients with metabolic syndrome, with a focus on treatment options and management of mixed dyslipidemia for reducing CVD risk. Medscape Cardiology
A cohort study showing an increased rate of hip bone loss suggests that the potential for bone loss should be considered when loop diuretics are prescribed to older patients in clinical practice. Medscape Medical News
